Dataset related to article "Neutrophil and lymphocyte blood count as potential predictive indicators of nivolumab efficacy in metastatic non-small-cell lung cancer"
Authors/Creators
- 1. Department of Oncology and Hematology– Humanitas Cancer Center – Rozzano (MI) – Italy
- 2. Department of Oncology and Hematology– Humanitas Cancer Center – Rozzano (MI) – Italy AND Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072 Pieve Emanuele – Milan, Italy
Description
This record contains raw data related to article “Neutrophil and lymphocyte blood count as potential predictive indicators of nivolumab efficacy in metastatic non-small-cell lung cancer"
The use of immune checkpoint inhibitors in pretreated metastatic non-small-cell lung cancer (mNSCLC) is, to date, limited by the lack of biomarkers able to reliably select patients that could potentially benefit from treatment and exclude subjects with intrinsic resistance. The aim of the present study is to evaluate the role of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) as prognostic factors in mNSCLC patients treated with nivolumab.
In this stud, medical records of 65 patients affected by mNSCLC and treated with nivolumab were retrospectively reviewed. NLR and LMR were calculated at baseline (t0) and at first radiological tumor assessment (t1).
Files
Restricted
The record is publicly accessible, but files are restricted. Log in to check if you have access.
Request access
If you would like to request access to these files, please fill out the form below.
You need to satisfy these conditions in order for this request to be accepted:
Restricted access for this data set is required because it contains sensitive data.
You are currently not logged in. Do you have an account? Log in here
Additional details
Related works
- Is supplement to
- 10.2217/imt-2019-0154 (DOI)
- 32522052 (PMID)